Products
Factor VII (Recombinant) / Anti-inhibitor
Factor VII products are used to manage acute bleeding or to prevent excessive bleeding as a treatment for patients with hemophilia, acquired inhibitors, or factor deficiency.
Nufactor carries the following F.D.A.-approved Factor VII Anti-Inhibitors (Congenital and/or Acquired Hemophilia) products:
* Denotes that Nufactor does not currently carry this product.
| Brand (Manufacturer) | FDA-Approved Indication(s) [abbreviated] |
|---|---|
|
|
|
|
|
|
|
|
1. HEMLIBRA is a bispecific factor IXa- and factor X-directed antibody indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors.
Last reviewed 08/08/24
